Literature DB >> 23643304

Multipotent mesenchymal stromal cells protect against kidney injury.

Florian E Tögel1, Joseph V Bonventre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23643304      PMCID： PMC4077161          DOI： 10.1016/j.jcyt.2013.04.005

Source DB:  PubMed          Journal:  Cytotherapy        ISSN： 1465-3249            Impact factor:   6.196


× No keyword cloud information.
  18 in total

1.  Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms.

Authors:  Florian Tögel; Zhuma Hu; Kathleen Weiss; Jorge Isaac; Claudia Lange; Christof Westenfelder
Journal:  Am J Physiol Renal Physiol       Date:  2005-02-15

2.  Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury.

Authors:  Marina Morigi; Cinzia Rota; Tiziana Montemurro; Elisa Montelatici; Viviana Lo Cicero; Barbara Imberti; Mauro Abbate; Carla Zoja; Paola Cassis; Lorena Longaretti; Paolo Rebulla; Martino Introna; Chiara Capelli; Ariela Benigni; Giuseppe Remuzzi; Lorenza Lazzari
Journal:  Stem Cells       Date:  2010-03-31       Impact factor: 6.277

3.  The MSC: an injury drugstore.

Authors:  Arnold I Caplan; Diego Correa
Journal:  Cell Stem Cell       Date:  2011-07-08       Impact factor: 24.633

4.  Mesenchymal-like progenitors derived from human embryonic stem cells promote recovery from acute kidney injury via paracrine actions.

Authors:  Jingfeng Luo; Xiaoli Zhao; Zhou Tan; Zhongyuan Su; Feilong Meng; Ming Zhang
Journal:  Cytotherapy       Date:  2013-02-14       Impact factor: 5.414

Review 5.  Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.

Authors:  Sudhir H Ranganath; Oren Levy; Maneesha S Inamdar; Jeffrey M Karp
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

6.  Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy.

Authors:  Marlies E J Reinders; Marieke Roemeling-van Rhijn; Meriem Khairoun; Ellen Lievers; Dorottya K de Vries; Alexander F M Schaapherder; San W S Wong; Jaap Jan Zwaginga; Jacques M Duijs; Anton Jan van Zonneveld; Martin J Hoogduijn; Willem E Fibbe; Johan W de Fijter; Cees van Kooten; Ton J Rabelink; Helene Roelofs
Journal:  Cytotherapy       Date:  2013-02-16       Impact factor: 5.414

7.  The effect of mesenchymal stromal cells on doxorubicin-induced nephropathy in rats.

Authors:  Hualin Ma; Yaojiong Wu; Wanfan Zhang; Yong Dai; Furong Li; Ying Xu; Yunshuai Wang; Huiying Tu; Wuxian Li; Xinzhou Zhang
Journal:  Cytotherapy       Date:  2013-03-14       Impact factor: 5.414

8.  Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study.

Authors:  Marlies E J Reinders; Johan W de Fijter; Helene Roelofs; Ingeborg M Bajema; Dorottya K de Vries; Alexander F Schaapherder; Frans H J Claas; Paula P M C van Miert; Dave L Roelen; Cees van Kooten; Willem E Fibbe; Ton J Rabelink
Journal:  Stem Cells Transl Med       Date:  2013-01-24       Impact factor: 6.940

9.  Stromal cells protect against acute tubular injury via an endocrine effect.

Authors:  Baoyuan Bi; Roland Schmitt; Malika Israilova; Hitoshi Nishio; Lloyd G Cantley
Journal:  J Am Soc Nephrol       Date:  2007-07-26       Impact factor: 10.121

10.  Inflammatory pre-conditioning of mesenchymal multipotent stromal cells improves their immunomodulatory potency in acute pyelonephritis in rats.

Authors:  Egor Y Plotnikov; Natalya V Pulkova; Irina B Pevzner; Ljubava D Zorova; Denis N Silachev; Maria A Morosanova; Gennady T Sukhikh; Dmitry B Zorov
Journal:  Cytotherapy       Date:  2013-04-02       Impact factor: 5.414
View more
  1 in total

Review 1.  Concise Review: Kidney Generation with Human Pluripotent Stem Cells.

Authors:  Ryuji Morizane; Tomoya Miyoshi; Joseph V Bonventre
Journal:  Stem Cells       Date:  2017-09-26       Impact factor: 6.277
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.